Pictet Asset Management (Switzerland)’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
FLAM
Pictet Asset Management (Switzerland)'s HCAT Position: Q3 2022 in Review
Pictet Asset Management (Switzerland) sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 403,136 shares — an estimated $5.84M sold.
Pictet Asset Management (Switzerland) first reported a position in HCAT in Q3 2021 and held it in 4 quarters. The position peaked at $21.7M in Q3 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.
- Pictet Asset Management (Switzerland) reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
- Pictet Asset Management (Switzerland) sold 403,136 Health Catalyst shares in Q3 2022, an estimated $5.84M.
- Pictet Asset Management (Switzerland) first reported a position in Health Catalyst in Q3 2021 and held it in 4 quarters.
- Pictet Asset Management (Switzerland)'s Health Catalyst position peaked at $21.7M in Q3 2021.
- 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.
Based on Pictet Asset Management (Switzerland)'s 13F filing for Q3 2022, filed 14 Nov 2022.